Johnson & Johnson (JNJ) Plans $1 Billion Sale of ‘Cerenovus’ Stroke Unit
Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...
Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates
Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...
Why Johnson & Johnson (JNJ) is the Best Medical Device Stock to Buy
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...
AOL12d
Is Johnson & Johnson Stock a Buy?
Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. If investing in a company came down to size, the stock would be a no-brainer buy. However ...
Johnson & Johnson reports progress on nipocalimab
HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...
Jim Cramer on Johnson & Johnson (JNJ): ‘Too Slow Growing’
We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Recently. In this article, we are going to take a ...
Johnson & Johnson Launches New Intraocular Lens TECNIS PureSee™ in India
Johnson & Johnson has launched the TECNIS PureSee™ intraocular lens in India, catering to individuals with presbyopia. The ...